OctoPlus develops pharmaceutical formulation solutions for an international client base in order to help bring innovative medicine from lab bench to the clinic and onto the market. In addition to our contract service activities, OctoPlus offers proprietary drug delivery technologies for the development of injectable pharmaceuticals that require less injections and induce less side effects.
View Top Employees from OctoPlusWebsite | http://www.octoplus.nl |
Revenue | $19 million |
Employees | 60 (36 on RocketReach) |
Founded | 1995 |
Phone | +31 71 524 4044 |
Fax | +31 71 524 4043 |
Technologies |
ASP.NET,
Apache,
Apache HTTP Server
+10 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Health Care, Pharmaceuticals, Manufacturing, Medical, Drug Delivery, Pharmaceutical, Formulation Development |
Competitors | BioZone Laboratories, Inc., Nektar Therapeutics, Orexo AB publ, Pii (Pharmaceutics International, Inc.)., Tris Pharma |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular OctoPlus employee's phone or email?
The OctoPlus annual revenue was $19 million in 2024.
Hans Delnoy is the Director of Operations of OctoPlus.
36 people are employed at OctoPlus.
The NAICS codes for OctoPlus are [325, 32, 32541, 3254].
The SIC codes for OctoPlus are [283, 28].